FDA Reports Spike in da Vinci Robot Surgery Injuries

Ava Lawson | December 6th, 2013

Based on recent spikes in adverse event reports of injury and death linked to the da Vinci robot, the FDA is recommending that patients discuss the benefits and associated risks of robotic surgery with their physician before undertaking any operation.  The da Vinci Surgical System has been utilized for a variety of gynecologic and thoracoscopic procedures since its launch in 2000… Read more »

Fosamax Jaw Injury MDL Disbanded

Ava Lawson | October 10th, 2013

Pharmaceutical giant Merck developed Fosamax to help men and women prevent and treat symptoms of osteoporosis. While the medication may help rebuild bone mass and slow bone degeneration in patients, Fosamax has been the topic of heated litigation over its adverse side effects. Individuals who filed Fosamax lawsuits against Merck argue they developed debilitating jaw injuries caused by osteonecrosis after… Read more »

BP Tries to Slow Down Oil Spill Claims Payments

Ava Lawson | September 27th, 2013

Nearly four years after the BP Deepwater Horizon Disaster of 2010, thousands of claimants are still waiting for their economic and medical settlements from British Petroleum. As of mid-September, the claims program had amassed 207,310 claims, of which only 119,301 have been processed. And of those, 46,490 have been denied. In light of BP’s recent efforts to cut company budgets… Read more »

Defective Device Lawsuit Loans Ease Suffering for DePuy ASR Plaintiffs

Jenn Fusion | September 19th, 2013

The first DePuy ASR hip replacement lawsuit was scheduled to be heard in federal court on September 9, 2013. However, Judge David A. Katz, who is presiding over the trials, issued an order on September 6 that delayed the trial another two weeks — until September 24. The judge says he conferred with both parties and determined that the case required… Read more »

Lipitor Lawsuit Funding Available for Products Liability Plaintiffs

Ava Lawson | August 19th, 2013

In a judicial order regarding Lipitor lawsuits and allegations of adverse side effects, the United States JPML concluded there were insufficient product liability claims in the federal court system to validate the coordination of such cases into multidistrict litigation, or MDL. The panel was presented with a motion this past April by a group of plaintiffs who identified five similar… Read more »